CareDx Inc.

7.66-0.0900-1.16%Vol 400.60K1Y Perf -51.74%
Sep 22nd, 2023 16:00 DELAYED
BID7.32 ASK7.95
Open7.80 Previous Close7.75
Pre-Market- After-Market7.70
 - -  0.04 0.52%
Target Price
28.00 
Analyst Rating
Moderate Buy 2.29
Potential %
265.54 
Finscreener Ranking
★★★★+     56.89
Insiders Trans % 3/6/12 mo.
-100/-100/-91 
Value Ranking
★★★★     57.22
Insiders Value % 3/6/12 mo.
-100/-100/-95 
Growth Ranking
★★★★     57.91
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-94 
Income Ranking
 —    -
Price Range Ratio 52W %
9.94 
Earnings Rating
Strong Sell
Market Cap414.93M 
Earnings Date
2nd Nov 2023
Alpha-0.01 Standard Deviation0.17
Beta0.95 

Today's Price Range

7.557.83

52W Range

6.2220.71

5 Year PE Ratio Range

-93.20-3.00

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-3.28%
1 Month
-12.66%
3 Months
-2.79%
6 Months
-13.25%
1 Year
-51.74%
3 Years
-75.53%
5 Years
-70.48%
10 Years
-

TickerPriceChg.Chg.%
CDNA7.66-0.0900-1.16
AAPL174.790.86000.49
GOOG131.25-0.1100-0.08
MSFT317.01-2.5200-0.79
XOM114.940.18000.16
WFC41.23-1.0900-2.58
JNJ160.50-1.1600-0.72
FB196.640.99000.51
GE111.25-1.7400-1.54
JPM145.73-1.4100-0.96
Financial StrengthValueIndustryS&P 500US Markets
5.10
5.50
0.07
0.09
-
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
65.60
-23.10
-18.40
-46.40
-24.34
RevenueValueIndustryS&P 500US Markets
239.41M
4.47
44.98
48.20
Earnings HistoryEstimateReportedSurprise %
Q02 2023-0.56-0.4617.86
Q01 2023-0.32-0.44-37.50
Q04 2022-0.36-0.345.56
Q03 2022-0.41-0.3221.95
Q02 2022-0.30-0.41-36.67
Q01 2022-0.30-0.37-23.33
Q04 2021-0.19-0.31-63.16
Q03 2021-0.14-0.23-64.29
Earnings Per EndEstimateRevision %Trend
9/2023 QR-0.67-63.41Negative
12/2023 QR-0.61-96.77Negative
12/2023 FY-2.21-38.99Negative
12/2024 FY-2.10-107.92Negative
Next Report Date2nd Nov 2023
Estimated EPS Next Report-0.67
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume400.60K
Shares Outstanding54.17K
Shares Float48.54M
Trades Count5.94K
Dollar Volume3.08M
Avg. Volume741.10K
Avg. Weekly Volume786.08K
Avg. Monthly Volume607.24K
Avg. Quarterly Volume829.97K

CareDx Inc. (NASDAQ: CDNA) stock closed at 7.66 per share at the end of the most recent trading day (a -1.16% change compared to the prior day closing price) with a volume of 400.60K shares and market capitalization of 414.93M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 475 people. CareDx Inc. CEO is Reginald Seeto.

The one-year performance of CareDx Inc. stock is -51.74%, while year-to-date (YTD) performance is -32.87%. CDNA stock has a five-year performance of -70.48%. Its 52-week range is between 6.2202 and 20.71, which gives CDNA stock a 52-week price range ratio of 9.94%

CareDx Inc. currently has a PE ratio of -8.00, a price-to-book (PB) ratio of 1.38, a price-to-sale (PS) ratio of 2.65, a price to cashflow ratio of 1 429.20, a PEG ratio of -, a ROA of -14.57%, a ROC of -15.73% and a ROE of -17.79%. The company’s profit margin is -24.34%, its EBITDA margin is -18.40%, and its revenue ttm is $239.41 Million , which makes it $4.47 revenue per share.

Of the last four earnings reports from CareDx Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.67 for the next earnings report. CareDx Inc.’s next earnings report date is 02nd Nov 2023.

The consensus rating of Wall Street analysts for CareDx Inc. is Moderate Buy (2.29), with a target price of $28, which is +265.54% compared to the current price. The earnings rating for CareDx Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

CareDx Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

CareDx Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 19.93, ATR14 : 0.45, CCI20 : -112.92, Chaikin Money Flow : -0.17, MACD : -0.42, Money Flow Index : 22.20, ROC : -13.05, RSI : 34.61, STOCH (14,3) : 7.59, STOCH RSI : 0.00, UO : 36.33, Williams %R : -92.41), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of CareDx Inc. in the last 12-months were: Bickerstaff George (Option Excercise at a value of $99 065), George W. Bickerstaff (Option Excercise at a value of $18 300), Maag Peter (Sold 2 432 shares of value $21 216 ), Peter Maag (Sold 10 701 shares of value $158 558 ), Reginald Seeto (Sold 54 407 shares of value $675 304 ), Seeto Reginald (Sold 19 905 shares of value $180 905 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (28.57 %)
2 (28.57 %)
2 (28.57 %)
Moderate Buy
1 (14.29 %)
1 (14.29 %)
0 (0.00 %)
Hold
4 (57.14 %)
4 (57.14 %)
5 (71.43 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.29
Moderate Buy
2.29
Moderate Buy
2.43

CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey, and is a leading provider of genomics-based information for transplant patients. Its primary operations are in Brisbane, California; Omaha, Nebraska; Fremantle, Australia and Stockholm, Sweden.

CEO: Reginald Seeto

Telephone: +1 415 287-2300

Address: 1 Tower Place, South San Francisco 94080, CA, US

Number of employees: 475

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

52%48%

Bearish Bullish

53%47%

Bearish Bullish

60%40%

 

TipRanks News for CDNA

Mon, 07 Aug 2023 12:55 GMT CareDx (CDNA) Gets a Hold from Craig-Hallum

- TipRanks. All rights reserved.

Tue, 11 Jul 2023 13:10 GMT Analysts Have Conflicting Sentiments on These Healthcare Companies: CareDx (CDNA), Omnicell (OMCL) and Xtant Medical Holdings (XTNT)

- TipRanks. All rights reserved.

News

Stocktwits